ClinicalTrials.govpublic full text
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
osteoporosis fracture, spinal cord injuries, bone mineral density, fracture, romosozumab, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857454
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.